No Detail Found!

Production of tissue culture based Peste des petits ruminants (PPR) vaccine at Casvab, Quetta, Pakistan.

Author(s)
Ferhat Abbas Center for Advanced Studies in Vaccinology and Biotechnology (CASVAB), University of Balochistan, Quetta, Pakistan
Asadullah Center for Advanced Studies in Vaccinology and Biotechnology (CASVAB), University of Balochistan, Quetta, Pakistan
Mohammad Arif Awan Center for Advanced Studies in Vaccinology and Biotechnology (CASVAB), University of Balochistan, Quetta, Pakistan
Mohammad Masood Tariq Center for Advanced Studies in Vaccinology and Biotechnology (CASVAB), University of Balochistan, Quetta, Pakistan
Mumtaz Ali Center for Advanced Studies in Vaccinology and Biotechnology (CASVAB), University of Balochistan, Quetta, Pakistan
Faisal Ameer Khan Center for Advanced Studies in Vaccinology and Biotechnology (CASVAB), University of Balochistan, Quetta, Pakistan
Masroor Ahmad Bajwa Center for Advanced Studies in Vaccinology and Biotechnology (CASVAB), University of Balochistan, Quetta, Pakistan
Zafar Ahmad Center for Advanced Studies in Vaccinology and Biotechnology (CASVAB), University of Balochistan, Quetta, Pakistan
Nadeem Rashid Center for Advanced Studies in Vaccinology and Biotechnology (CASVAB), University of Balochistan, Quetta, Pakistan
Abdul-Wadood Center for Advanced Studies in Vaccinology and Biotechnology (CASVAB), University of Balochistan, Quetta, Pakistan
Abstract
Peste des petits ruminant (PPR) is an acute disease of small ruminants which causes low productivity as well as great economic losses in many countries including Pakistan. There has been pressing need to control this disease through vaccination in Pakistan. The aim of this discussion is to convey the production of an efficacious vaccine against PPR disease in Pakistan. Tissue culture based live freeze-dried PPR virus (PPR 75-1) vaccine was produced using Vero cell line at the Center for Advance Studies in Vaccinology and Biotechnology (CASVAB), University of Balochistan, Quetta in 2007. The vaccine was checked for validation, safety, sterility and efficacy using the standard procedures set by Office International des Epizooties (OIE) terrestrial manual for vaccine production. In total 3.1 million doses have been produced from 2007 to 2010. The PPR vaccine of 0.0923 million doses have been given free of cost to Livestock and Dairy Development Department, Government of Balochistan, Pakistan for immuno-prophylaxis against PPR disease in goats in various districts of Balochistan. Moreover approximately 3 million doses were also distributed commercially to different organizations nationwide. It is anticipated that the PPR vaccine prepared at CASVAB would be an effective tool to limit PPR disease in goats as well as to reduce economic losses due to this disease in Pakistan.
Publication Details
Page(s) 80-83
DOI DOI not available
Published Journal: Pakistan Journal of Life and Social Sciences, Volume: 10, Issue: 1, Year: 2012

Request the full text from PASTIC

0

Citations

0

Downloads

37

Views